Fuller & Thaler Asset Management
GNMK

Fuller & Thaler Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Fuller & Thaler Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-175,641
Closed -$2.58M – 535
2020
Q2 		$2.58M Buy
+175,641
New +$1.78M 0.03% 268

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fuller & Thaler Asset Management's GNMK Position: Q3 2020 in Review

Fuller & Thaler Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2020, closing a stake of 175,641 shares — an estimated $2.58M sold.

Fuller & Thaler Asset Management first reported a position in GNMK in Q2 2020 and held it in 1 quarter. The position peaked at $2.58M in Q2 2020. 163 funds tracked by Wall St. Rank hold GNMK as of Q3 2020.

  • Fuller & Thaler Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q3 2020 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 175,641 GenMark Diagnostics, Inc shares in Q3 2020, an estimated $2.58M.
  • Fuller & Thaler Asset Management first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 1 quarter.
  • Fuller & Thaler Asset Management's GenMark Diagnostics, Inc position peaked at $2.58M in Q2 2020.
  • 163 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2020.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.